» Articles » PMID: 17204652

Differential Antigen Processing by Dendritic Cell Subsets in Vivo

Overview
Journal Science
Specialty Science
Date 2007 Jan 6
PMID 17204652
Citations 671
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) process and present self and foreign antigens to induce tolerance or immunity. In vitro models suggest that induction of immunity is controlled by regulating the presentation of antigen, but little is known about how DCs control antigen presentation in vivo. To examine antigen processing and presentation in vivo, we specifically targeted antigens to two major subsets of DCs by using chimeric monoclonal antibodies. Unlike CD8+ DCs that express the cell surface protein CD205, CD8- DCs, which are positive for the 33D1 antigen, are specialized for presentation on major histocompatibility complex (MHC) class II. This difference in antigen processing is intrinsic to the DC subsets and is associated with increased expression of proteins involved in MHC processing.

Citing Articles

Forced intracellular degradation of xenoantigens as a modality for cell-based cancer immunotherapy.

Bikorimana J, Farah R, Abusarah J, Mandl G, Erregragui M, Goncalves M iScience. 2025; 28(3):111957.

PMID: 40060894 PMC: 11889607. DOI: 10.1016/j.isci.2025.111957.


Long noncoding RNA PARAL1 regulates myeloid dendritic cell differentiation and TLR signaling.

Naqvi R, Valverde A, Shukla D, Naqvi A Genes Immun. 2025; .

PMID: 40000873 DOI: 10.1038/s41435-025-00323-9.


RORγt-expressing dendritic cells are functionally versatile and evolutionarily conserved antigen-presenting cells.

Narasimhan H, Richter M, Shakiba R, Papaioannou N, Stehle C, Ravi Rengarajan K Proc Natl Acad Sci U S A. 2025; 122(9):e2417308122.

PMID: 39993193 PMC: 11892598. DOI: 10.1073/pnas.2417308122.


Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials.

Hussain Z, Zhang Y, Qiu L, Gou S, Liu K NPJ Vaccines. 2025; 10(1):27.

PMID: 39920156 PMC: 11806010. DOI: 10.1038/s41541-025-01084-2.


Shared pathway of WDFY4-dependent cross-presentation of immune complexes by cDC1 and cDC2.

Jo S, Ohara R, Theisen D, Kim S, Liu T, Bullock C J Exp Med. 2025; 222(4).

PMID: 39918736 PMC: 11804880. DOI: 10.1084/jem.20240955.